BGS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
B&G Foods (BGS) is not a good buy right now for a beginner investor focused on long-term holding. The stock has a high dividend yield, but the underlying business and balance sheet look weak, and recent earnings trends are negative. With no strong proprietary buy signal, mixed technicals, insider selling, and deteriorating fundamentals, I would not buy it now. For an impatient investor, this is still a hold rather than a buy.
BGS is trading around 5.43, just above the pivot at 5.418 and below near-term resistance at 5.582. The moving averages are technically constructive with SMA_5 > SMA_20 > SMA_200, which suggests short-term trend support. However, MACD histogram is slightly negative and worsening, and RSI_6 at 50.94 is neutral with no clear momentum. Overall, the chart shows a fragile short-term setup with limited upside unless it breaks resistance decisively.
High dividend yield around 13% may attract income-focused buyers. Gross margin improved to 21.82% in the latest quarter, showing some operational stabilization. Analysts have modestly raised price targets to $6 and $5, indicating some improvement in sentiment. The company also has an earnings event coming up on 2026-05-12, which could provide a catalyst if results exceed expectations.
Revenue fell 2.18% YoY in Q4 2025, net income dropped 93.18%, and EPS turned sharply worse. Debt remains very high at 4.4x debt-to-equity, and interest coverage is only 1.3x, which is a major financial weakness. The dividend was cut 60% in 2022, so the headline yield is not especially secure. News also highlights pressure from consumer budget tightening and energy costs. Insider selling has increased 214.24% over the last month. The stock trend model also points to weakness over the next week and month.
In 2025/Q4, B&G Foods showed weak fundamentals: revenue declined to 539.6M, down 2.18% YoY. Net income fell to -15.2M, down 93.18% YoY, and EPS dropped to -0.19, down 93.24% YoY. Gross margin improved to 21.82% from last year, which is a positive sign, but it does not offset the decline in profitability and overall earnings weakness.
Recent analyst sentiment has improved only slightly: Barclays raised its price target from $4 to $5, then to $6, while maintaining Equal Weight; Evercore ISI raised its target to $5 and kept In Line. The tone is cautious rather than bullish, with concerns about input costs and dividend sustainability. Wall Street’s pros see some stabilization and leverage improvement potential, but the cons dominate: weak earnings, debt concerns, and uncertainty around the dividend.
